2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Tuesday, June 14, 2016

2:30pm-2:42pm: Ischemia Reperfusion Induced Murine Heart Transplant Rejection Is Complement Dependent.

N. Chun,¹ M. Zhang,² R. Fairchild,³ P. Heeger.¹

Concurrent Session: Ischemic Injury and Organ Preservation: Animal Models • Room 313

2:30pm-2:42pm: Microfluidics to Characterize Leukocyte Trafficking into Allografts and the Resolution of Inflammation.

L. Boneschansker,^1,2 D. Irimia,² D. Briscoe.¹

Concurrent Session: T Cell Biology and Alloimmunity: Animal Models • Room 310

2:30pm-2:42pm: Polyclonal Treg Adoptive Therapy for Control of Subclinical Kidney Transplant Inflammation (TASK Pilot Trial).

S. Chandran, Q. Tang, M. Sarwal, Z. Laszik, A. Putnam, T. Sigdel, E. Tavares, J. Bluestone, F. Vincenti.

Concurrent Session: Kidney Immunosuppression: Novel Agents • Veterans Auditorium

2:30pm-2:42pm: Pregnancy Excludes Women from Successful Living Donor Transplantation.

P. Porrett,¹ B. Bromberger,² S. Hashmi,¹ A. Morrison,¹ D. Sawinski.³

Concurrent Session: Disparities in Transplant Access and Outcomes • Room 312

2:30pm-2:42pm: Rapamycin Encapsulated Nanoparticles as Pre-Treatment in Lung Transplantation.

G. Bazzle,¹ S. Dixit,² K. Patel,³ A.-M. Broome,² S. Nadig,^1,3 C. Atkinson.^1,3

Concurrent Session: Allograft Tolerance 2: Animal Models • Room 309

2:30pm-2:42pm: Successful Treatment of Hepatitis C in Renal Transplant Recipients with Directly Acting Antiviral Agents.

M. Lubetzky,¹ S. Chun,¹ A. Joelson,¹ E. Akalin,¹ P. Gaglio,² G. DeBoccardo.¹

Concurrent Session: It's Just Not the Donor: Impact of Recipient Factors on Outcomes • Ballroom A

2:30pm-2:42pm: Survival Benefit of DCD Livers.

X. Luo, A. Massie, D. Segev.

Concurrent Session: Liver: MELD, Allocation and Donor Issues (DCD/ECD) 1 • Room 304

2:42pm-2:54pm: A Molecular Biopsy Test for Probability of Non-Adherence.

P. Halloran,^1,3 G. Einecke,² J. Reeve.¹

Concurrent Session: Kidney Immunosuppression: Novel Agents • Veterans Auditorium

2:42pm-2:54pm: African-American Primary Renal Transplant Recipients Are at a Significantly Higher Risk to Develop De Novo DSA.

M. Everly,¹ L. Rebellato,² C. Haisch,² K. Briley,² P. Bolin,² S. Kendrick,³ C. Morgan,² A. Maldonado,⁴ A. Nguyen,¹ P. Terasaki.¹

Concurrent Session: Disparities in Transplant Access and Outcomes • Room 312

2:42pm-2:54pm: Analysis of FSGS (Focal Segmental Glomerulosclerosis) Recurrence After Renal Transplantation.

J. Mansur, G. Basso, M. Cristelli, G. Mata, T. Sandes-Freitas, G. Kirsztajn, H. Tedesco-Silva, J. Medina-Pestana.

Concurrent Session: It's Just Not the Donor: Impact of Recipient Factors on Outcomes • Ballroom A